FOXO4-DRI Peptide – Research Grade Senolytic Peptide

Product Overview

FOXO4-DRI Peptide is a synthetic research peptide designed based on a functional region of the human FOXO4 protein. It is engineered using a D-retro-inverso peptide design strategy to improve molecular stability and resistance to enzymatic degradation during laboratory research applications.

FOXO4-DRI is primarily investigated as a senescence-related research peptide, focusing on the molecular mechanisms involved in cellular senescence, apoptosis regulation, and FOXO4/p53 signaling pathways.

This peptide is supplied as a research-grade compound for qualified laboratories, biotechnology companies, and academic research institutions.

1. What is FOXO4-DRI Peptide?

Identity & Research Positioning

FOXO4-DRI Peptide is a synthetic peptide analog derived from the FOXO4 protein interaction domain.

FOXO4 (Forkhead Box O4) is a member of the FOXO transcription factor family involved in cellular stress response, apoptosis regulation, and longevity-associated signaling pathways.

FOXO4-DRI was developed as a molecular research tool to investigate the interaction between FOXO4 and p53, particularly in the context of cellular senescence mechanisms.

Research Classification:

• Synthetic peptide
• Senescence pathway research compound
• FOXO4/p53 interaction research tool
• Apoptosis signaling research peptide

2. Peptide Category Classification

Research Peptide Category

FOXO4-DRI belongs to the following research peptide categories:

Primary Category:

Senolytic Research Peptide

Secondary Categories:

• Cell Senescence Research Peptides
• Apoptosis Pathway Research Compounds
• Protein-Protein Interaction Research Peptides
• Longevity Biology Research Tools

Unlike conventional signaling peptides, FOXO4-DRI is primarily studied for its ability to modulate specific intracellular protein interactions associated with senescent cell survival mechanisms.

3. Research Logic & Mechanism

Molecular Research Rationale

Cellular senescence is a biological state where cells permanently stop dividing while remaining metabolically active.

Senescent cells may contribute to aging-related biological processes through secretion of inflammatory signaling molecules known as SASP (Senescence-Associated Secretory Phenotype).

Research has investigated whether selectively targeting senescent cell survival pathways may provide insights into age-associated cellular regulation.

FOXO4-DRI research focuses on:

• FOXO4 and p53 protein interaction
• Regulation of apoptosis pathways
• Senescent cell survival mechanisms
• Cellular stress response signaling

The D-retro-inverso modification is designed to enhance peptide stability while maintaining biological research activity.

4. Research Evidence (Research Findings)

Published Research Findings

Research studies investigating FOXO4-DRI have reported:

Cellular Senescence Studies

• FOXO4-DRI has been evaluated as a molecular tool for studying senescent cell survival pathways.
• Research models have examined its influence on FOXO4-p53 interactions.

Apoptosis Pathway Research

Studies have investigated whether disruption of FOXO4-mediated regulation may influence apoptotic signaling in senescent cell models.

Aging Biology Research

Preclinical research has explored FOXO4-DRI as a tool for understanding:

• Cellular aging mechanisms
• Tissue regeneration biology
• Senescence-associated pathways

Note: Current evidence is primarily based on laboratory and preclinical research models. Human clinical validation remains limited.

5. Research Applications

Laboratory Research Applications

FOXO4-DRI Peptide may be used in qualified research environments for:

Cellular Senescence Research

Applications include:

• Senescent cell biology studies
• Aging-related cellular mechanisms
• SASP pathway investigation

Molecular Biology Research

Potential research areas:

• FOXO4 signaling studies
• p53 pathway investigation
• Protein interaction analysis

Cell Culture Research

Common laboratory applications:

• In vitro cellular models
• Molecular pathway screening
• Experimental biology research

Biotechnology Research

Potential use areas:

• Aging biology programs
• Cellular regulation studies
• Drug discovery research platforms

6. Safety Profile

Research Safety Considerations

FOXO4-DRI is an experimental research peptide and has not been approved as a pharmaceutical compound.

Current safety information is primarily derived from laboratory research settings.

Important research considerations include:

• Biological activity may vary depending on experimental models.
• Long-term effects have not been fully characterized.
• Effects in humans have not been established.
• Appropriate laboratory handling procedures should be followed.

Researchers should evaluate peptide suitability according to their own experimental requirements and institutional guidelines.

7. Final Product Positioning

Research Grade FOXO4-DRI Peptide

FOXO4-DRI Peptide is positioned as:

A high-quality research peptide for laboratories investigating cellular senescence, apoptosis regulation, and FOXO4-related molecular pathways.

Recommended customers:

• Biotechnology companies
• Academic laboratories
• Pharmaceutical research organizations
• Molecular biology research facilities

Product advantages:

✓ Research-grade synthesis
✓ Analytical quality verification
✓ Batch-specific documentation
✓ Suitable for laboratory research applications

8. Quality Documentation

Quality Control Documentation Provided

Each FOXO4-DRI peptide batch may be supported with analytical documentation including:

Certificate of Analysis (COA)

The COA provides batch-specific quality information, including:

• Product identification
• Batch number
• Purity specification
• Testing results
• Quality verification data

HPLC Report

High Performance Liquid Chromatography (HPLC) analysis is used for peptide purity assessment.

Typical information includes:

• Chromatographic profile
• Purity percentage
• Retention time analysis

Mass Spectrometry

Mass spectrometry testing confirms molecular identity through:

• Expected molecular weight verification
• Peptide identification
• Structural confirmation analysis

Batch Documentation

Available batch records may include:

• Manufacturing information
• Quality control records
• Testing documentation
• Storage and handling requirements

9. Storage Information

Recommended Storage Conditions

For maintaining peptide stability:

• Store in a dry, sealed container
• Keep protected from moisture
• Store at recommended laboratory temperatures
• Avoid repeated freeze-thaw cycles
• Reconstituted solutions should be handled according to laboratory protocols

Storage conditions may vary depending on formulation, packaging, and experimental requirements.

10. Research Disclaimer

Research Use Only

FOXO4-DRI Peptide is supplied strictly for laboratory research purposes.

For research use only.

Not intended for human consumption.

Not intended for clinical or diagnostic use.

This product is not a dietary supplement, pharmaceutical product, medical treatment, or therapeutic agent.

Customers are responsible for ensuring compliance with applicable regulations and institutional research standards.

11. FAQ – B2B SEO Questions

1. What is FOXO4-DRI peptide used for in research?

FOXO4-DRI peptide is primarily researched as a molecular tool for studying cellular senescence, FOXO4/p53 interactions, and apoptosis-related pathways.

2. Is FOXO4-DRI a senolytic research peptide?

FOXO4-DRI is classified as a senescence-related research peptide and has been investigated for potential senolytic mechanisms in laboratory models.

3. What quality documents are available for FOXO4-DRI peptide?

Research suppliers typically provide documentation including COA, HPLC analysis reports, mass spectrometry data, and batch-specific quality records.

4. How is FOXO4-DRI peptide synthesized?

FOXO4-DRI is a synthetic peptide designed using a D-retro-inverso modification strategy to improve molecular stability for research applications.

5. What purity level is available for research-grade FOXO4-DRI?

Research-grade FOXO4-DRI products are typically supplied with analytical purity verification through HPLC testing. Actual specifications depend on supplier quality standards and batch results.

6. Can FOXO4-DRI peptide be used for human applications?

No. FOXO4-DRI peptide is provided strictly as a laboratory research compound and is not intended for human consumption, clinical use, or diagnostic applications.

7. How should FOXO4-DRI peptide be stored?

FOXO4-DRI should be stored according to supplier-recommended laboratory storage conditions, with protection from moisture, heat, and unnecessary freeze-thaw cycles.

8. Who typically purchases FOXO4-DRI research peptide?

Typical customers include biotechnology companies, academic institutions, pharmaceutical research laboratories, and organizations conducting molecular biology studies.